Clinical Trial Update: A Real-world Study to Assess Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China

View source ↗

Summary

A real-world safety study evaluating OZURDEX in adults with diabetic macular edema in China; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: AbbVie | Conditions: Diabetic Macular Edema | Status: ACTIVE_NOT_RECRUITING